SpIntellx

About:

Shaping the Future of Spatially Intelligent Biology

Twitter/X: spintellx

Top Investors: National Science Foundation, Innovation Works, Keiretsu Capital, AlphaLab Health, Newlin Investment Company

Description:

SpIntellx has the first-mover advantage in Precision Pathology and Spatially Intelligent Biology by applying truly unbiased spatial analytics software powered by explainable AI to decipher the complex cancer biology. SpIntellx’s software solutions have the potential to unlock a plethora of new applications in medicine and research by answering the fundamental question “Why?”, thus revealing the underlying patient-specific disease network biology, across each stage of the drug development, diagnostics, and treatment pipelines.

Total Funding Amount:

$1.67M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Pittsburgh, Pennsylvania, United States

Founded Date:

2017-01-01

Contact Email:

INFO(AT)SPINTELLX.COM

Founders:

Chakra Chennubhotla, Jeffrey Fine, Lansing Taylor, Michael Becich

Number of Employees:

1-10

Last Funding Date:

2023-02-28

IPO Status:

Private

Industries: